Endothelial cells potentiate interferon-γ production in a novel tripartite culture model of human cerebral malaria.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 3709908)

Published in PLoS One on July 12, 2013

Authors

Loke Tim Khaw1, Helen J Ball, Jacob Golenser, Valery Combes, Georges E Grau, Julie Wheway, Andrew J Mitchell, Nicholas H Hunt

Author Affiliations

1: School of Medical Sciences and Bosch Institute, University of Sydney, Sydney, Australia.

Articles cited by this

Human malaria parasites in continuous culture. Science (1976) 59.70

Human natural killer cells. Blood (2008) 7.37

Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med (1989) 6.79

Genetic analysis of the human malaria parasite Plasmodium falciparum. Science (1987) 6.48

TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet (1990) 6.32

Intercellular adhesion molecule-1 is an endothelial cell adhesion receptor for Plasmodium falciparum. Nature (1989) 5.62

IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol (2002) 4.81

Immunological processes in malaria pathogenesis. Nat Rev Immunol (2005) 3.80

Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment. Pharmacol Ther (1998) 3.57

Adhesion of Plasmodium falciparum-infected erythrocytes to hyaluronic acid in placental malaria. Nat Med (2000) 3.40

A low interleukin-10 tumor necrosis factor-alpha ratio is associated with malaria anemia in children residing in a holoendemic malaria region in western Kenya. J Infect Dis (1999) 3.26

Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol (2003) 3.18

Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor. Proc Natl Acad Sci U S A (1989) 3.03

Malarial hemozoin is a Nalp3 inflammasome activating danger signal. PLoS One (2009) 2.93

Adhesion of Plasmodium falciparum-infected erythrocytes to human cells: molecular mechanisms and therapeutic implications. Expert Rev Mol Med (2009) 2.77

Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J Exp Med (1996) 2.75

CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science (1999) 2.60

The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria. J Infect Dis (1999) 2.49

Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria. Lancet (1998) 2.39

Rapid activation of endothelial cells enables Plasmodium falciparum adhesion to platelet-decorated von Willebrand factor strings. Blood (2009) 2.18

Innate immune response to malaria: rapid induction of IFN-gamma from human NK cells by live Plasmodium falciparum-infected erythrocytes. J Immunol (2002) 2.12

Immunopathogenesis of cerebral malaria. Int J Parasitol (2006) 2.08

Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria. Proc Natl Acad Sci U S A (2008) 2.08

Malarial hemozoin activates the NLRP3 inflammasome through Lyn and Syk kinases. PLoS Pathog (2009) 2.07

Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria. J Immunol (1996) 2.07

Plasmodium falciparum-infected erythrocytes demonstrate dual specificity for adhesion to hyaluronic acid and chondroitin sulfate A and have distinct adhesive properties. J Infect Dis (2004) 2.06

Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans. Clin Microbiol Rev (2001) 1.91

Cerebral malaria: why experimental murine models are required to understand the pathogenesis of disease. Parasitology (2009) 1.87

Locally up-regulated lymphotoxin alpha, not systemic tumor necrosis factor alpha, is the principle mediator of murine cerebral malaria. J Exp Med (2002) 1.86

Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens. Nat Rev Immunol (2007) 1.84

Cerebral malaria: the contribution of studies in animal models to our understanding of immunopathogenesis. Microbes Infect (2002) 1.81

Low levels of RANTES are associated with mortality in children with cerebral malaria. J Infect Dis (2006) 1.79

Cerebrospinal fluid cytokine levels and cognitive impairment in cerebral malaria. Am J Trop Med Hyg (2008) 1.69

Involvement of IFN-gamma receptor-medicated signaling in pathology and anti-malarial immunity induced by Plasmodium berghei infection. Eur J Immunol (2000) 1.68

Immune-mediated mechanisms of parasite tissue sequestration during experimental cerebral malaria. J Immunol (2010) 1.65

Plasma interleukin-10:Tumor necrosis factor (TNF)-alpha ratio is associated with TNF promoter variants and predicts malarial complications. J Infect Dis (2000) 1.64

Specific receptor usage in Plasmodium falciparum cytoadherence is associated with disease outcome. PLoS One (2011) 1.62

Innate immune responses to human malaria: heterogeneous cytokine responses to blood-stage Plasmodium falciparum correlate with parasitological and clinical outcomes. J Immunol (2006) 1.62

IP-10-mediated T cell homing promotes cerebral inflammation over splenic immunity to malaria infection. PLoS Pathog (2009) 1.61

Plasmodium falciparum erythrocyte membrane protein-1 specifically suppresses early production of host interferon-gamma. Cell Host Microbe (2007) 1.61

Platelets reorient Plasmodium falciparum-infected erythrocyte cytoadhesion to activated endothelial cells. J Infect Dis (2004) 1.57

Development and regulation of cell-mediated immune responses to the blood stages of malaria: implications for vaccine research. Annu Rev Immunol (2005) 1.53

Activation of a subset of human NK cells upon contact with Plasmodium falciparum-infected erythrocytes. J Immunol (2003) 1.52

Platelets potentiate brain endothelial alterations induced by Plasmodium falciparum. Infect Immun (2006) 1.51

Interferon-γ--central mediator of protective immune responses against the pre-erythrocytic and blood stage of malaria. J Leukoc Biol (2010) 1.51

Natural killer cell and macrophage cooperation in MyD88-dependent innate responses to Plasmodium falciparum. Proc Natl Acad Sci U S A (2005) 1.50

Pure Hemozoin is inflammatory in vivo and activates the NALP3 inflammasome via release of uric acid. J Immunol (2009) 1.48

CD8+ T cells and IFN-γ mediate the time-dependent accumulation of infected red blood cells in deep organs during experimental cerebral malaria. PLoS One (2011) 1.47

Plasmodium falciparum-infected erythrocytes induce NF-kappaB regulated inflammatory pathways in human cerebral endothelium. Blood (2009) 1.46

Cross-talk between T cells and NK cells generates rapid effector responses to Plasmodium falciparum-infected erythrocytes. J Immunol (2010) 1.43

Supraorbital postmortem brain sampling for definitive quantitative confirmation of cerebral sequestration of Plasmodium falciparum parasites. J Infect Dis (2012) 1.42

Chemokine gene expression during fatal murine cerebral malaria and protection due to CXCR3 deficiency. J Immunol (2008) 1.42

Parasite-derived plasma microparticles contribute significantly to malaria infection-induced inflammation through potent macrophage stimulation. PLoS Pathog (2010) 1.39

Role of ICAM-1 (CD54) in the development of murine cerebral malaria. Microbes Infect (1999) 1.37

The CXCR3 binding chemokine IP-10/CXCL10: structure and receptor interactions. Biochemistry (2002) 1.33

Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria. Am J Pathol (1998) 1.32

Resistance to cerebral malaria in tumor necrosis factor-alpha/beta-deficient mice is associated with a reduction of intercellular adhesion molecule-1 up-regulation and T helper type 1 response. Am J Pathol (1997) 1.32

Interleukin-10 inhibits tumor necrosis factor production but not antigen-specific lymphoproliferation in acute Plasmodium falciparum malaria. J Infect Dis (1995) 1.26

Emerging paradigms of T-cell co-stimulation. Curr Opin Immunol (2004) 1.22

gammadelta-T cells expressing NK receptors predominate over NK cells and conventional T cells in the innate IFN-gamma response to Plasmodium falciparum malaria. Eur J Immunol (2007) 1.21

CXCR3 determines strain susceptibility to murine cerebral malaria by mediating T lymphocyte migration toward IFN-gamma-induced chemokines. Eur J Immunol (2008) 1.20

Heterogeneous human NK cell responses to Plasmodium falciparum-infected erythrocytes. J Immunol (2005) 1.20

Regulation of the expression of ICAM-1 on human monocytes and monocytic tumor cell lines. J Immunol (1992) 1.17

Role of platelet adhesion in homeostasis and immunopathology. Mol Pathol (1997) 1.16

Plasmodium falciparum adhesion on human brain microvascular endothelial cells involves transmigration-like cup formation and induces opening of intercellular junctions. PLoS Pathog (2010) 1.16

Platelet microparticles: a new player in malaria parasite cytoadherence to human brain endothelium. FASEB J (2009) 1.14

Cytokine regulation of ICAM-1 expression on human renal tubular epithelial cells in vitro. Transplantation (1991) 1.13

Multiple var gene transcripts are expressed in Plasmodium falciparum infected erythrocytes selected for adhesion. Mol Biochem Parasitol (2001) 1.09

T lymphocyte interferon-gamma production induced by Plasmodium falciparum antigen is high in recently infected non-immune and low in immune subjects. Clin Exp Immunol (1990) 1.09

Regulation of immunity and pathogenesis in infectious diseases by CD1d-restricted NKT cells. Int J Parasitol (2004) 1.08

Caspase-1 activation of interleukin-1β (IL-1β) and IL-18 is dispensable for induction of experimental cerebral malaria. Infect Immun (2011) 1.02

CXCL4 and CXCL10 predict risk of fatal cerebral malaria. Dis Markers (2011) 1.00

TLR9 polymorphisms are associated with altered IFN-gamma levels in children with cerebral malaria. Am J Trop Med Hyg (2010) 1.00

Plasmodium-induced inflammation by uric acid. PLoS Pathog (2008) 0.99

Expression of major histocompatibility complex antigens on mouse brain microvascular endothelial cells in relation to susceptibility to cerebral malaria. Immunology (1997) 0.93

Dissection of the role of PfEMP1 and ICAM-1 in the sensing of Plasmodium-falciparum-infected erythrocytes by natural killer cells. PLoS One (2007) 0.92

Platelets alter gene expression profile in human brain endothelial cells in an in vitro model of cerebral malaria. PLoS One (2011) 0.92

Activation of human NK cells by malaria-infected red blood cells. Methods Mol Biol (2010) 0.82

Toll-like receptor polymorphisms and cerebral malaria: TLR2 Δ22 polymorphism is associated with protection from cerebral malaria in a case control study. Malar J (2012) 0.82

Iron chelators: correlation between effects on Plasmodium spp. and immune functions. J Parasitol (2006) 0.81

Cerebral malaria pathogenesis: what can we learn from microarray analysis? Am J Pathol (2007) 0.78

Articles by these authors

Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome. J Clin Invest (2002) 4.14

Immunological processes in malaria pathogenesis. Nat Rev Immunol (2005) 3.80

Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol (2003) 3.18

Peptidomic discovery of short open reading frame-encoded peptides in human cells. Nat Chem Biol (2012) 2.95

A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends Parasitol (2006) 2.90

B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells. J Immunol (2004) 2.54

Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice. Gene (2007) 2.24

Rapid activation of endothelial cells enables Plasmodium falciparum adhesion to platelet-decorated von Willebrand factor strings. Blood (2009) 2.18

Kynurenine is an endothelium-derived relaxing factor produced during inflammation. Nat Med (2010) 2.12

Immunopathogenesis of cerebral malaria. Int J Parasitol (2006) 2.08

Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells. Nat Immunol (2013) 1.91

Current perspectives on the mechanism of action of artemisinins. Int J Parasitol (2006) 1.80

The role of animal models for research on severe malaria. PLoS Pathog (2012) 1.76

Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway. Int J Biochem Cell Biol (2008) 1.64

Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. Diabetes (2002) 1.61

Circulating endothelial microparticles in malawian children with severe falciparum malaria complicated with coma. JAMA (2004) 1.60

Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice. PLoS One (2012) 1.59

Platelets potentiate brain endothelial alterations induced by Plasmodium falciparum. Infect Immun (2006) 1.51

TNF deficiency fails to protect BAFF transgenic mice against autoimmunity and reveals a predisposition to B cell lymphoma. J Immunol (2004) 1.47

Imaging experimental cerebral malaria in vivo: significant role of ischemic brain edema. J Neurosci (2005) 1.45

Chemokine gene expression during fatal murine cerebral malaria and protection due to CXCR3 deficiency. J Immunol (2008) 1.42

Parasite-derived plasma microparticles contribute significantly to malaria infection-induced inflammation through potent macrophage stimulation. PLoS Pathog (2010) 1.39

Murine cerebral malaria development is independent of toll-like receptor signaling. Am J Pathol (2007) 1.38

Perforin mediated apoptosis of cerebral microvascular endothelial cells during experimental cerebral malaria. Int J Parasitol (2006) 1.35

Early cytokine production is associated with protection from murine cerebral malaria. Infect Immun (2005) 1.32

Circulating red cell-derived microparticles in human malaria. J Infect Dis (2011) 1.30

Glioma microvesicles carry selectively packaged coding and non-coding RNAs which alter gene expression in recipient cells. RNA Biol (2013) 1.26

The role of granulocyte macrophage-colony-stimulating factor in acute intestinal inflammation. Cell Res (2008) 1.26

Murine cerebral malaria: the whole story. Trends Parasitol (2010) 1.24

TGF-beta1 released from activated platelets can induce TNF-stimulated human brain endothelium apoptosis: a new mechanism for microvascular lesion during cerebral malaria. J Immunol (2006) 1.22

Dual ERK and phosphatidylinositol 3-kinase pathways control airway smooth muscle proliferation: differences in asthma. J Cell Physiol (2008) 1.18

Chemical alterations to murine brain tissue induced by formalin fixation: implications for biospectroscopic imaging and mapping studies of disease pathogenesis. Analyst (2011) 1.17

Platelet-endothelial cell interactions in cerebral malaria: the end of a cordial understanding. Thromb Haemost (2009) 1.16

Detection and characterization of OX40 ligand expression in human airway smooth muscle cells: a possible role in asthma? J Allergy Clin Immunol (2004) 1.16

Plasmodium falciparum adhesion on human brain microvascular endothelial cells involves transmigration-like cup formation and induces opening of intercellular junctions. PLoS Pathog (2010) 1.16

Gene-expression profiling discriminates between cerebral malaria (CM)-susceptible mice and CM-resistant mice. J Infect Dis (2005) 1.15

Plasmodium falciparum rhoptry protein RSP2 triggers destruction of the erythroid lineage. Blood (2005) 1.15

Tumor necrosis factor-alpha and angiostatin are mediators of endothelial cytotoxicity in bronchoalveolar lavages of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med (2002) 1.14

Platelet microparticles: a new player in malaria parasite cytoadherence to human brain endothelium. FASEB J (2009) 1.14

Cerebral malaria -- a neurovascular pathology with many riddles still to be solved. Curr Neurovasc Res (2004) 1.14

Microparticle-associated nucleic acids mediate trait dominance in cancer. FASEB J (2011) 1.13

Gene expression analysis reveals early changes in several molecular pathways in cerebral malaria-susceptible mice versus cerebral malaria-resistant mice. BMC Genomics (2007) 1.10

Inhibition of endothelial activation: a new way to treat cerebral malaria? PLoS Med (2005) 1.09

Pathophysiology of cerebral malaria: role of host cells in the modulation of cytoadhesion. Ann N Y Acad Sci (2003) 1.09

A contrast agent recognizing activated platelets reveals murine cerebral malaria pathology undetectable by conventional MRI. J Clin Invest (2008) 1.09

CD40 and OX40 ligand are increased on stimulated asthmatic airway smooth muscle. J Allergy Clin Immunol (2005) 1.08

Cytochrome b5, not superoxide anion radical, is a major reductant of indoleamine 2,3-dioxygenase in human cells. J Biol Chem (2008) 1.08

Artemisone effective against murine cerebral malaria. Malar J (2010) 1.07

Brain gene expression, metabolism, and bioenergetics: interrelationships in murine models of cerebral and noncerebral malaria. FASEB J (2004) 1.06

Magnetic resonance spectroscopy reveals an impaired brain metabolic profile in mice resistant to cerebral malaria infected with Plasmodium berghei ANKA. J Biol Chem (2007) 1.06

Glutathione is involved in the antimalarial action of chloroquine and its modulation affects drug sensitivity of human and murine species of Plasmodium. Redox Rep (2003) 1.06

pfmdr2 confers heavy metal resistance to Plasmodium falciparum. J Biol Chem (2006) 1.05

Protection against cerebral malaria by the low-molecular-weight thiol pantethine. Proc Natl Acad Sci U S A (2008) 1.04

Pathogenic role of P-selectin in experimental cerebral malaria: importance of the endothelial compartment. Am J Pathol (2004) 1.03

Coincident parasite and CD8 T cell sequestration is required for development of experimental cerebral malaria. Int J Parasitol (2010) 1.03

The clinical significance of cerebrospinal fluid levels of kynurenine pathway metabolites and lactate in severe malaria. J Infect Dis (2002) 1.03

Technical advance: autofluorescence as a tool for myeloid cell analysis. J Leukoc Biol (2010) 1.02

The microcirculation in severe malaria. Microcirculation (2004) 1.02

Microvesiculation and cell interactions at the brain-endothelial interface in cerebral malaria pathogenesis. Prog Neurobiol (2010) 1.02

Metabolites of the kynurenine pathway of tryptophan metabolism in the cerebrospinal fluid of Malawian children with malaria. J Infect Dis (2003) 1.01

Cell vesiculation and immunopathology: implications in cerebral malaria. Microbes Infect (2006) 1.01

Heme moves to center stage in cerebral malaria. Nat Med (2007) 1.01

A murine model of infection with Rickettsia prowazekii: implications for pathogenesis of epidemic typhus. Microbes Infect (2007) 0.99

Increased expression of indoleamine 2,3-dioxygenase in murine malaria infection is predominantly localised to the vascular endothelium. Int J Parasitol (2004) 0.98

Indoleamine 2,3-dioxygenase 2 (IDO2) and the kynurenine pathway: characteristics and potential roles in health and disease. Amino Acids (2013) 0.98

CNS hypoxia is more pronounced in murine cerebral than noncerebral malaria and is reversed by erythropoietin. Am J Pathol (2011) 0.97

Prostaglandin E(2) inhibits calcium current in two sub-populations of acutely isolated mouse trigeminal sensory neurons. J Physiol (2002) 0.96

Probucol promotes functional reendothelialization in balloon-injured rabbit aortas. Circulation (2003) 0.96

Placental hypoxia during placental malaria. J Infect Dis (2008) 0.96

Interferon-gamma synergises with tumour necrosis factor and lymphotoxin-alpha to enhance the mRNA and protein expression of adhesion molecules in mouse brain endothelial cells. Cytokine (2007) 0.96

Isolating vessels from the mouse brain for gene expression analysis using laser capture microdissection. Brain Res Brain Res Protoc (2002) 0.96

Gp91(phox) contributes to the development of experimental inflammatory bowel disease. Immunol Cell Biol (2011) 0.95